Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase II Feasibility Study of Fecal Microbiota Transplant (FMT) in Advanced Melanoma Patients Not Responding to PD-1 Blockade

NCT03341143 is registered in ClinicalTrials.gov with Zarour, Hassane, MD as lead sponsor.

NCT NCT03341143
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03341143 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase II Feasibility Study of Fecal Microbiota Transplant (FMT) in Advanced Melanoma Patients Not Responding to PD-1 Blockade
Lead sponsor
Zarour, Hassane, MD
Phase
Phase 2
Overall status
Completed
Start date
March 19, 2018
Completion date
September 30, 2024
Enrollment
20 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

melanoma